(Q48296941)

10 February 2018

title

Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures (English)

1 reference

10 February 2018

author name string

Dean C

series ordinal

1

1 reference

10 February 2018

Mosier M

series ordinal

2

1 reference

10 February 2018

Penry K

series ordinal

3

1 reference

10 February 2018

publication date

1 January 1999

1 reference

10 February 2018

published in

Epilepsia

1 reference

10 February 2018

volume

40

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

74-82

1 reference

10 February 2018

GABAergic mechanisms in the pathogenesis and treatment of epilepsy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB01991.X

Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB01991.X

Severe persistent visual field constriction associated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB01991.X

Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB01991.X

Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB01991.X

10.1111/J.1528-1157.1999.TB01991.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018